EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.1.1.67 | A154T | polymorphism TPMT*3B | Mammalia |
2.1.1.67 | A154T/Y240C | polymorphism TPMT*3A | Mammalia |
2.1.1.67 | A154T/Y240C/E98STOP | polymorphism TPMT*3D | Mammalia |
2.1.1.67 | A80P | polymorphism TPMT*2 | Mammalia |
2.1.1.67 | C132Y | polymorphism TPMT*11 | Mammalia |
2.1.1.67 | E28V | polymorphism TPMT*13 | Mammalia |
2.1.1.67 | G144R | polymorphism TPMT*10 | Mammalia |
2.1.1.67 | G36S/K238E | polymorphism TPMT*20 | Mammalia |
2.1.1.67 | G71R | polymorphism TPMT*18 | Mammalia |
2.1.1.67 | H227E | polymorphism TPMT*7 | Mammalia |
2.1.1.67 | K122T | polymorphism TPMT*19 | Mammalia |
2.1.1.67 | L49S | polymorphism TPMT*5 | Mammalia |
2.1.1.67 | L69V | polymorphism TPMT*21 | Mammalia |
2.1.1.67 | additional information | no amino acid substitutions in the polymorphisms TPMT*4 and TPMT*15, Met-Val substitution in the start codon of TPMT*14 | Mammalia |
2.1.1.67 | Q42E | polymorphism TPMT*17 | Mammalia |
2.1.1.67 | R163H | polymorphism TPMT*16 | Mammalia |
2.1.1.67 | R163P | polymorphism TPMT*22 | Mammalia |
2.1.1.67 | R215H | polymorphism TPMT*8 | Mammalia |
2.1.1.67 | S125L | polymorphism TPMT*12 | Mammalia |
2.1.1.67 | Y180F | polymorphism TPMT*6 | Mammalia |
2.1.1.67 | Y240C | polymorphism TPMT*3C | Mammalia |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.1.1.67 | aspirin | - |
Mammalia | |
2.1.1.67 | bendroflumethiazide | - |
Mammalia | |
2.1.1.67 | Disulfiram | - |
Mammalia | |
2.1.1.67 | Furosemide | - |
Mammalia | |
2.1.1.67 | mesalazine | - |
Mammalia | |
2.1.1.67 | olsalazine | - |
Mammalia | |
2.1.1.67 | sulfasalazine | - |
Mammalia | |
2.1.1.67 | trichlormethiazide | - |
Mammalia |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.1.1.67 | cytosol | - |
Mammalia | 5829 | - |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
2.1.1.67 | 35000 | - |
- |
Mammalia |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.67 | S-adenosyl-L-methionine + a thiopurine | Mammalia | - |
S-adenosyl-L-homocysteine + a thiopurine S-methylether | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.67 | Mammalia | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.1.1.67 | erythrocyte | - |
Mammalia | - |
2.1.1.67 | heart | - |
Mammalia | - |
2.1.1.67 | intestine | - |
Mammalia | - |
2.1.1.67 | kidney | - |
Mammalia | - |
2.1.1.67 | liver | - |
Mammalia | - |
2.1.1.67 | lymphocyte | - |
Mammalia | - |
2.1.1.67 | pancreas | - |
Mammalia | - |
2.1.1.67 | placenta | - |
Mammalia | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.67 | S-adenosyl-L-methionine + 6-mercaptopurine | - |
Mammalia | S-adenosyl-L-homocysteine + 6-methylmercaptopurine | - |
? | |
2.1.1.67 | S-adenosyl-L-methionine + 6-thioguanine | - |
Mammalia | S-adenosyl-L-homocysteine + 6-methylthioguanine | - |
? | |
2.1.1.67 | S-adenosyl-L-methionine + 6-thioinosine-monophosphate | - |
Mammalia | S-adenosyl-L-homocysteine + 6-methylthioinosine-monophosphate | - |
? | |
2.1.1.67 | S-adenosyl-L-methionine + a thiopurine | - |
Mammalia | S-adenosyl-L-homocysteine + a thiopurine S-methylether | - |
? | |
2.1.1.67 | S-adenosyl-L-methionine + azathioprine | azathioprine is converted to mercaptopurine, which is subsequently metabolized through TPMT | Mammalia | S-adenosyl-L-homocysteine + 6-methylmercaptopurine + ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.1.1.67 | thiopurine S-methyltransferase | - |
Mammalia |
2.1.1.67 | TPMT | - |
Mammalia |